Recall Register

Food, drugs, devices › Shionogi Inc.

Drug recall: Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Man

FDA enforcement event 78851 · Class III · initiated 24 May 2017 · status Terminated · terminated 28 Feb 2018

DrugVoluntary: Firm initiated1 product recordAlpharetta, GA

Shionogi Inc. (Alpharetta, GA) initiated this drug recall on 24 May 2017; FDA lists 1 product record under event 78851, classified Class III.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 30% of the 343 drug enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 28 Feb 2018. Initiation: voluntary: firm initiated. Shionogi Inc. has 4 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Shionogi Inc., Alpharetta, GA.

Reason for recall

"Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules"

Distribution

"U.S.A. Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
D-0219-2018Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OH 45040, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ 07981, NDC 66993-070-30968 bottlesClass IIITerminated24 Jan 2018

Context

30%of 2017 drug events are Class III343 events that year
1product record in this eventfirm median: 1
4events on this register for the firm

Other enforcement events for Shionogi Inc.

InitiatedProduct (first record)TypeClassRecords
24 May 2017Mefenamic Acid, 250mg capsules, packaged in 30-count bottles, Rx Only, Distributed by: Prasco Laboratories Mason, OH 450DrugClass III2
24 Jul 2015Nisoldipine Extended Release Tablets, 17 mg, packaged as a) Sular (nisoldipine) Extended Release tablets, 100-count bottDrugClass III1
8 Mar 2012Nisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only, Manufactured for: Prasco Laboratories Mason OH 45DrugClass II1

All 4 events for Shionogi Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "U.S.A. Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Feb 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.